跳至主要内容
临床试验/NCT03890887
NCT03890887已完成1 期

Relative Bioavailability of a Single Oral Dose of BI 1291583 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects (an Open-label, Two-period, Fixed Sequence Study)

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2019年4月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Area under the concentration-time curve of BI 1291583 in plasma over the time interval from 0 to the last quantifiable data point

研究概览

简要总结

The main objective of this trial is to investigate the relative bioavailability of BI 1291583 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test, T) as compared to when given alone as oral single dose (Reference, R).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

All subjects: Reference followed by Test treatments

Experimental

Reference - BI 1291583 alone. Test - BI 1291583 + Itraconazole

干预措施: BI 1291583 (Drug)

All subjects: Reference followed by Test treatments

Experimental

Reference - BI 1291583 alone. Test - BI 1291583 + Itraconazole

干预措施: Itraconazole (Drug)

结局指标

主要结局

Area under the concentration-time curve of BI 1291583 in plasma over the time interval from 0 to the last quantifiable data point

时间窗: Up to 263 hours.

Maximum measured concentration of BI 1291583 in plasma

时间窗: Up to 263 hours.

次要结局

  • Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity(Up to 263 hours.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study in Healthy Men to Test How Itraconazole... | 临床试验